Cisen Pharmaceutical Co., Ltd. (603367.SS)
CNY 13.94
(1.6%)
CNY 13.94
(1.6%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 592.57 Million CNY | 62.54% |
| 2022 | 364.58 Million CNY | 9.02% |
| 2021 | 334.42 Million CNY | -31.0% |
| 2020 | 484.67 Million CNY | -16.82% |
| 2019 | 582.71 Million CNY | 3.02% |
| 2018 | 565.61 Million CNY | 35.9% |
| 2017 | 416.2 Million CNY | 54.37% |
| 2016 | 269.61 Million CNY | -0.14% |
| 2015 | 269.99 Million CNY | 11.76% |
| 2014 | 241.57 Million CNY | 16.11% |
| 2013 | 208.06 Million CNY | -36.27% |
| 2012 | 326.48 Million CNY | 20.83% |
| 2011 | 270.18 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 65.87 Million CNY | -63.9% |
| 2024 Q1 | 182.47 Million CNY | 6.61% |
| 2024 Q3 | 145.69 Million CNY | 121.17% |
| 2023 Q2 | 119.47 Million CNY | -30.11% |
| 2023 FY | 592.57 Million CNY | 62.54% |
| 2023 Q1 | 170.94 Million CNY | 154.37% |
| 2023 Q3 | 130.98 Million CNY | 9.63% |
| 2023 Q4 | 171.16 Million CNY | 30.68% |
| 2022 Q1 | 103.59 Million CNY | 210.98% |
| 2022 FY | 364.58 Million CNY | 9.02% |
| 2022 Q4 | 67.2 Million CNY | -37.2% |
| 2022 Q3 | 107.01 Million CNY | 23.35% |
| 2022 Q2 | 86.76 Million CNY | -16.25% |
| 2021 Q1 | 119.72 Million CNY | -2.05% |
| 2021 FY | 334.42 Million CNY | -31.0% |
| 2021 Q4 | 33.31 Million CNY | -68.23% |
| 2021 Q3 | 104.86 Million CNY | 37.04% |
| 2021 Q2 | 76.51 Million CNY | -36.09% |
| 2020 Q3 | 167.12 Million CNY | 117.88% |
| 2020 FY | 484.67 Million CNY | -16.82% |
| 2020 Q4 | 122.23 Million CNY | -26.86% |
| 2020 Q2 | 76.7 Million CNY | -35.33% |
| 2020 Q1 | 118.6 Million CNY | 13.45% |
| 2019 Q1 | 143.67 Million CNY | 5.23% |
| 2019 Q2 | 142.89 Million CNY | -0.54% |
| 2019 Q3 | 191.6 Million CNY | 34.09% |
| 2019 FY | 582.71 Million CNY | 3.02% |
| 2019 Q4 | 104.54 Million CNY | -45.44% |
| 2018 Q3 | 160.26 Million CNY | 28.7% |
| 2018 Q2 | 124.52 Million CNY | -13.7% |
| 2018 Q1 | 144.29 Million CNY | -23.33% |
| 2018 FY | 565.61 Million CNY | 35.9% |
| 2018 Q4 | 136.53 Million CNY | -14.8% |
| 2017 Q4 | 188.19 Million CNY | 117.82% |
| 2017 Q3 | 86.4 Million CNY | 14.22% |
| 2017 Q2 | 75.64 Million CNY | 14.68% |
| 2017 Q1 | 65.96 Million CNY | -26.79% |
| 2017 FY | 416.2 Million CNY | 54.37% |
| 2016 Q3 | 83.09 Million CNY | 0.0% |
| 2016 Q4 | 90.1 Million CNY | 8.43% |
| 2016 FY | 269.61 Million CNY | -0.14% |
| 2015 Q1 | 69.26 Million CNY | 0.0% |
| 2015 Q2 | 69.26 Million CNY | 0.0% |
| 2015 FY | 269.99 Million CNY | 11.76% |
| 2014 FY | 241.57 Million CNY | 16.11% |
| 2013 FY | 208.06 Million CNY | -36.27% |
| 2012 FY | 326.48 Million CNY | 20.83% |
| 2011 FY | 270.18 Million CNY | 0.0% |